Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 6/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | MERTK | Q12866 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | WNK1 | Q9H4A3 | 1/20 | 0.54 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.53 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.53 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31519032 | 1.00 | L3MBTL1 (0.62) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL31519031 | 1.00 | L3MBTL1 (0.62) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL11901853 | 0.88 | TDP1 (0.59) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL11518576 | 0.86 | MAPT (0.66) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL11514562 | 0.85 | KAT2B (0.51) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL1762228 | 0.85 | LRRK2 (0.51) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL2649258 | 0.85 | LRRK2 (0.51) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL2653998 | 0.85 | MEN1 (0.55) | L3MBTL1MAPTALDH1A1TDP1MAPK1 | |
| SCHEMBL2276207 | 0.84 | LRRK2 (0.55) | L3MBTL1MAPTALDH1A1TDP1HCAR3 | |
| SCHEMBL27227167 | 0.82 | MERTK (0.56) | L3MBTL1MAPTALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136628-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-05-01 | — | — | US | disclosed |
| US-7622594-B2 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090140637-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ELECTRON-ATTRACTING SUBSTITUENT AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20070060633-A1 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136628-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRD1 | L3MBTL1 1865/4885MAPT 3226/4885ALDH1A1 1023/4885 |
| US-20070060633-A1 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | NR3C1, MC2R, NR3C2 | L3MBTL1 3685/4885MAPT 322/4885ALDH1A1 2756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.